<DOC>
	<DOCNO>NCT01280461</DOCNO>
	<brief_summary>This phase III , multi-center , open-label , comparative randomize study evaluate efficacy safety cefoperazone/sulbactam versus cefepime treatment hospital-acquired pneumonia healthcare-associated pneumonia . The investigator determine total duration study therapy , clinically indicate . The minimum duration study therapy 7 day maximum allowable duration study therapy 21 day .</brief_summary>
	<brief_title>An Open-label , Randomized , Comparative Study Evaluate Efficacy Safety Cefoperazone/Sulbactam Comparison Cefepime Treatment Hospital-acquired Pneumonia Healthcare-associated Pneumonia</brief_title>
	<detailed_description>Patients fulfill inclusion/exclusion criterion randomly assign ( 1:1 ratio ) receive intravenous cefoperazone/sulbactam intravenous cefepime 7~21days . Vitamin K1 10mg administer cefoperazone/sulbactam group every 24 hour . The assessment clinical sign symptom pneumonia microbiological test perform early post-therapy visit test-of-cure visit .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Cefoperazone</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<mesh_term>Sulperazone</mesh_term>
	<criteria>Male female patient age ≧18 year old Patients nosocomial bacterial pneumonia least 48 hour hospitalization patient healthcareassociated pneumonia ( HCAP* ) . Clinical finding At least two follow sign : 1 . Cough 2 . Fever : axillary temperature &gt; 37.5℃ tympanic temperature &gt; 38.5℃ 3 . Hypothermia : axillary temperature &lt; 34℃ tympanic temperature &lt; 35℃ 4 . Purulent sputum production respiratory secretion 5 . Total peripheral white blood cell ( WBC ) count &gt; 10,000/mm3 ; &gt; 15 % band form , regardless total peripheral white count ; leucopenia total WBC &lt; 4500/mm3 6 . Auscultatory finding pulmonary examination rale and/or evidence pulmonary consolidation ( dullness percussion , bronchial breath sound , egophony ) 7 . Hypoxemia ( define partial O2 pressure &lt; 60 mmHg patient breathe normal air decrease partial O2 pressure ≧25 % initial value ) Radiographic find The chest radiograph show presence new progressive infiltration chest Xray film Microbiologic criterion If sputum specimen available collect , test mandatory least one follow result positive : ( 1 ) Within 24 hour prior , time enrollment , patient culture susceptibility test respiratory secretion sputum study drug ( 2 ) Gram stain respiratory secretion sputum Patient must able sign write informed consent form prior start study procedure . If patient unable give consent , must obtain patient 's legal representative Subject receive 24 hour parenteral antibacterial drug current pneumonia . If subject receive 24 hour parenteral antibacterial drug , he/she must declare treatment failure . Woman pregnant ( determined urine test ) lactate state Patients know bronchial obstruction history postobstructive pneumonia . ( This exclude patient chronic obstructive pulmonary disease ) A neutrophil count &lt; 1000/mm3 Patients pneumonia due viral , fungal , mycobacterial infection . Patients know infected human immunodeficiency virus Documented Legionella pneumonia Patients infected gram negative ( G ) microorganism know resistant one study antibiotic trial Subjects sputum gram stain PMN &gt; 25 , epithelial cell &lt; 10 , gram positive ( G+ ) cocci cluster predominant phagocytosis Patients receive investigational drug within 30 day prior enrollment Patients receive medication like cefoperazone , cefoperazone/sulbactam cefepime within 30 day prior enrollment Patients abnormal pretherapy laboratory data : aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) ≧ 3X ULN ( upper limit normal ) ; serum creatinine , urea nitrogen &gt; 3X ULN A history hypersensitivity penicillin , cephalosporin , carbapenems Jlactam/Jlactamase inhibitor Severe disease ( eg . septic shock , acute respiratory distress syndrome , multiple organ failure ) may limit survival therapy followup period , confound result study judged investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Pneumonia</keyword>
</DOC>